Aardvark Therapeutics Registration Statement Effective
Ticker: AARD · Form: EFFECT · Filed: Apr 6, 2026 · CIK: 0001774857
Sentiment: neutral
Topics: registration-statement, effectiveness
TL;DR
Aardvark Therapeutics registration statement is now effective as of 4/3/2026.
AI Summary
Aardvark Therapeutics, Inc. (CIK: 0001774857) filed an EFFECT form, indicating the effectiveness of a registration statement, on April 6, 2026. The effectiveness date is noted as April 3, 2026. The company is located at 4370 La Jolla Village Drive, Suite 1050, San Diego, CA 92122.
Why It Matters
This filing signifies that Aardvark Therapeutics' registration statement has been declared effective by the SEC, allowing for the potential sale of securities.
Risk Assessment
Risk Level: medium — The effectiveness of a registration statement is a procedural step that can precede significant financial events, carrying inherent market risks.
Key Numbers
- 333-294537 — File Number (SEC registration file number)
Key Players & Entities
- Aardvark Therapeutics, Inc. (company) — Filer
- 0001774857 (company) — CIK
- 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122 (address) — Mailing and Business Address
- 2026-04-06 (date) — Acceptance Date
- 2026-04-03 (date) — Effectiveness Date
FAQ
What type of filing is this?
This is an EFFECT filing, which signifies the effectiveness of a registration statement.
When was the filing accepted by the SEC?
The filing was accepted on 2026-04-06.
What is the effectiveness date of the registration statement?
The effectiveness date is 2026-04-03.
What is the CIK number for Aardvark Therapeutics, Inc.?
The CIK number for Aardvark Therapeutics, Inc. is 0001774857.
What is the business address of Aardvark Therapeutics, Inc.?
The business address is 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122.
Filing Stats: 33 words · 1 min read · ~1 pages · Grade level 9.8 · Accepted 2026-04-06 00:15:13
Filing Documents
- primary_doc.html (EFFECT)
- primary_doc.xml (EFFECT) — 1KB
- 9999999995-26-001083.txt ( ) — 2KB
From the Filing
Notice of Effectiveness UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Notice of Effectiveness Effectiveness Date: April 3, 2026 4:00 P.M. Form: S-3 CIK: Company Name: Aardvark Therapeutics, Inc. File Number: 333-294537